TD Waterhouse Canada’s Ascendis Pharma A/S ASND Stock Holding History

TD Waterhouse Canada’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87K	Buy	+7	New	+$1.64K	﹤0.01%	2130
2025 Q4	–	Sell	-2,790	Closed	-$569K	–	2050
2025 Q3	$569K	Sell	2,790 -265	-9%	-$49.4K	﹤0.01%	650
2025 Q2	$525K	Buy	3,055 +204	+7%	+$33.2K	﹤0.01%	643
2025 Q1	$432K	Buy	2,851 +103	+4%	+$14.7K	﹤0.01%	658
2024 Q4	$378K	Buy	2,748 +50	+2%	+$6.57K	﹤0.01%	668
2024 Q3	$395K	Buy	2,698 +193	+8%	+$26.1K	﹤0.01%	641
2024 Q2	$336K	Buy	2,505 +2,341	+1,427%	+$319K	﹤0.01%	663
2024 Q1	$24K	Buy	+164	New	+$23.4K	﹤0.01%	1203

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TD Waterhouse Canada's ASND Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 7 shares worth $1.87K. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings. This is a return to the name: TD Waterhouse Canada previously reported a position in ASND as recently as Q3 2025.

TD Waterhouse Canada first reported a position in ASND in Q1 2024 and has held it in 8 quarters since. The position peaked at $569K in Q3 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

TD Waterhouse Canada held 7 shares of Ascendis Pharma A/S worth $1.87K as of Q2 2026.
Ascendis Pharma A/S was a new TD Waterhouse Canada position in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2130 holding.
TD Waterhouse Canada first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 8 quarters since.
TD Waterhouse Canada's Ascendis Pharma A/S position peaked at $569K in Q3 2025.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.